CCDF Multi-Stakeholder Workshop, 18 – 19 June 2019, Amsterdam, Netherlands
Involving patients in oncology drug development
aPODD Trustee, Debbie Binner, is attending the Cancer Drug Development Forum (CDDF) workshop, in Amsterdam. The CDDF’s mission is to encourage conversations between all those involved in developing cancer drugs in order to accelerate the delivery of effective treatments to patients.
This workshop will look at the opportunities and challenges of incorporating the patient-relevant evidence into oncology drug development and approval process from the perspective of patients, health care providers, health authorities, HTA bodies, payers and industry and will address the following topics
· Examine the different type of patient-relevant evidence for patient-focused drug development
· Exemplary models for interactions between patients’ communities, sponsors and decision-makers
· Examples of qualitative and quantitative patient-experience data and its contribution to development, review, approval and access to new drugs.
If you would like to arrange a meeting with Debbie at the workshop, and find out more about aPODD’s commitment to accelerate access for children and young adults to new cancer drugs email via the link below.